Mon, April 1, 2024
Sun, March 31, 2024
Thu, March 28, 2024
Wed, March 27, 2024

Emily Bodnar Reiterated (ACRV) at Strong Buy and Held Target at $20 on, Mar 28th, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-20-on-mar-28th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Emily Bodnar of HC Wainwright & Co., Reiterated "Acrivon Therapeutics, Inc." (ACRV) at Strong Buy and Held Target at $20 on, Mar 28th, 2024.

Emily has made no other calls on ACRV in the last 4 months.



There is 1 other peer that has a rating on ACRV. Out of the 1 peers that are also analyzing ACRV, 0 agree with Emily's Rating of Hold.



This is the rating of the analyst that currently disagrees with Emily


  • Silvan Tuerkcan of "JMP Securities" Initiated at Buy and Held Target at $14 on, Friday, March 1st, 2024

Publication Contributing Sources